Overview
Status
Active
Registry date
2011-09-08
Share capital
3 343 900,00 PLN
Registered address
ul. Krzemieniecka 48C, 54-613 Wrocław, Poland
Electronic delivery address
AE:PL-76944-58966-DBGCR-25
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 2.07mMedianUSD 38.31kAverageUSD 2.31m
Net profit
This companyUSD 51.42kMedianUSD -1.50kAverageUSD -84.98k
Operating costs
This companyUSD 1.72mMedianUSD 56.25kAverageUSD 2.29m
Assets
This companyUSD 15.15mMedianUSD 116.77kAverageUSD 2.72m
Industry
Bank accounts
Registered as a VAT taxpayer on 2011-10-10. Active
13 1240 6410 1111 0011 4963 1229- 17 1240 6410 1111 0010 8402 1327
20 1020 4900 0000 8502 3031 5782
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
18 public aid cases recorded, with a total value of $4,518,154.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 27, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $13,632$13,632 | Prezes Banku Gospodarstwa Krajowego | |
| May 8, 2025 | Aid for research and development projects: industrial research | $880.2K$880,164 | Marszałek Województwa Śląskiego | |
| May 8, 2025 | Aid for research and development projects: experimental development | $227.9K$227,866 | Marszałek Województwa Śląskiego |
European Funds
7 projects recorded: 4 from FE lists ($7,315,133) and 3 Commission grants (FTS) ($1,158,780).
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-02-01 | Opracowanie innowacyjnej bazy lipidowej o działaniu radioprotekcyjnym | $2.4M$2,394,877 | Fundusze Europejskie dla Śląskiego 2021-2027 | |
| 2024-12-01 | Badania nad liposomową postacią żelaza z wykorzystaniem autorskich rozwiązań technologicznych celem wdrożenia produktu leczniczego opartego o nanotechnologie liposomowe. | $2.6M$2,572,409 | Fundusze Europejskie dla Nowoczesnej Gospodarki | |
| 2022-09-01 | 101057318 - Regerna - cardiac regeneration by mrna-triggered proliferation of cardiomyocytes | $695.3K$695,268 | 1.0.11 - Horizon Europe |
Tenders
1 tender recorded as contractor, with a total value of $15,506.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jun 2, 2025 | Dostawa zsyntetyzowanych liposomów zawierających kontrast służący do obrazowania magnetyczno-rezonansowego (MRI), dla potrzeb Jagiellońskiego Centrum Rozwoju Leków (JCET) w Krakowie. | $15,506$15,506 | Uniwersytet Jagielloński |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Magdalena Justyna Przybyło — President of the Management Board
Manner of representation
Each member of the management board is authorized to represent the company individually.
Ownership
| Owner | Shares | Stake |
|---|---|---|
Lipid Systems Langner, Przybyło Sp. J. | 32,050 | 48.9395% |
Twiti Investments Ltd. | 33,439 | 51.0605% |
Beneficial owners
8 beneficial owners recorded in CRBR.
| Person | Rights | |
|---|---|---|
Adam Aleksandrowicz (26)  | Other natural person. | |
Michał Aleksandrowicz (28) | Other natural person. | |
Paweł Aleksandrowicz (36) | Other natural person. | |
Robert Aleksandrowicz (60) | Other natural person. | |
Tomasz Częścik (58) | Natural person exercising control on behalf of a supervisory body. | |
Christos Kinanis (67)  | Natural person exercising control on behalf of a supervisory body | |
Marek Józef Langner (70) | Wspólnik w spółce osobowej posiadającej 47% udziałów w spółce | |
Magdalena Justyna Przybyło (46) | Wspólnik w spółce osobowej posiadającej 47% udziałów w spółce |
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Lipotechsp. z o.o. | 1,350.62 USD | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| Proteon PharmaceuticalsS.A. | $2,026,826.52 | proteonpharmaspolkaakcyjna.pl | ||
| SkinlabP.S.A. | $1,797,229.06 | skinlab.pl | ||
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl | ||
| VASA Therapeuticssp. z o.o. | $216,535.01 | vasatherapeutics.com | ||
| MultiqureS.A. | $149,394.35 | purebiologics.com | ||
| GenomtecS.A. | $54,746.36 | genomtec.com | ||
| Centrum Transferu Technologii Meditransfer Iitdsp. z o.o. | $228.56 | iitd.pan.wroc.pl | ||
| Olenasp. z o.o. | — | imsolutions.pl |
Change history
| Date | Event | |
|---|---|---|
| 2020-01-29 | Share capital change (3,205,000.00 PLN → 3,343,900.00 PLN) | |
| 2016-10-07 | Address change (Ul. Krzemieniecka 48b, 54-613, Wrocław → Ul. Krzemieniecka 48c, 54-613, Wrocław) | |
| 2016-07-20 | Address change (Duńska 9, 54-427, Wrocław → Ul. Krzemieniecka 48b, 54-613, Wrocław) | |
| 2016-07-20 | Share capital change (3,200,000.00 PLN → 3,205,000.00 PLN) | |
| 2016-07-20 | PKD change (Removed: 33.20.Z, 74.10.Z, 74.30.Z, 74.90.Z, 85.59.B, 85.60.Z, 86.90.E; Added: 10.89.Z) |
FAQ
Last updated: 2026-07-17